First Bankers Trust’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.9M Buy
9,048
+66
+0.7% +$67.4K 3.38% 3
2026
Q1
$8.26M Sell
8,982
-303
-3% -$307K 2.79% 5
2025
Q4
$9.98M Buy
9,285
+404
+5% +$386K 3.35% 3
2025
Q3
$6.78M Sell
8,881
-68
-0.8% -$50.6K 2.36% 6
2025
Q2
$6.98M Sell
8,949
-291
-3% -$226K 2.58% 4
2025
Q1
$7.63M Sell
9,240
-675
-7% -$562K 3.01% 3
2024
Q4
$7.65M Sell
9,915
-195
-2% -$161K 2.99% 4
2024
Q3
$8.96M Sell
10,110
-662
-6% -$595K 3.44% 3
2024
Q2
$9.75M Sell
10,772
-223
-2% -$178K 4.03% 3
2024
Q1
$8.55M Sell
10,995
-950
-8% -$676K 3.65% 3
2023
Q4
$6.96M Sell
11,945
-287
-2% -$168K 3.23% 4
2023
Q3
$6.57M Sell
12,232
-1,559
-11% -$803K 3.31% 4
2023
Q2
$6.47M Sell
13,791
-1,233
-8% -$517K 3.17% 4
2023
Q1
$5.16M Sell
15,024
-3,854
-20% -$1.3M 2.59% 5
2022
Q4
$6.91M Sell
18,878
-685
-4% -$243K 3.55% 2
2022
Q3
$6.33M Sell
19,563
-30
-0.2% -$9.51K 3.63% 3
2022
Q2
$6.35M Sell
19,593
-63
-0.3% -$18.9K 3.33% 3
2022
Q1
$5.63M Sell
19,656
-1,246
-6% -$321K 2.62% 5
2021
Q4
$5.77M Sell
20,902
-561
-3% -$142K 2.54% 5
2021
Q3
$4.96M Sell
21,463
-555
-3% -$137K 2.49% 5
2021
Q2
$5.05M Sell
22,018
-5,920
-21% -$1.19M 2.46% 6
2021
Q1
$5.22M Sell
27,938
-1,469
-5% -$287K 2.18% 7
2020
Q4
$4.96M Sell
29,407
-295
-1% -$44K 1.91% 13
2020
Q3
$4.4M Sell
29,702
-2,321
-7% -$359K 1.87% 14
2020
Q2
$5.26M Sell
32,023
-155
-0.5% -$23.8K 2.35% 5
2020
Q1
$4.46M Sell
32,178
-490
-1% -$67.3K 2.31% 7
2019
Q4
$4.29M Sell
32,668
-518
-2% -$60K 1.81% 16
2019
Q3
$3.71M Sell
33,186
-998
-3% -$111K 1.68% 18
2019
Q2
$3.79M Sell
34,184
-3,693
-10% -$435K 1.75% 18
2019
Q1
$4.92M Sell
37,877
-40,437
-52% -$4.92M 2.34% 7
2018
Q4
$9.06M Buy
78,314
+36,425
+87% +$4.07M 2.36% 7
2018
Q3
$4.5M Sell
41,889
-2,213
-5% -$221K 2.14% 10
2018
Q2
$3.76M Sell
44,102
-1,577
-3% -$130K 1.95% 14
2018
Q1
$3.53M Sell
45,679
-1,613
-3% -$130K 1.86% 15
2017
Q4
$3.99M Sell
47,292
-16
-0% -$1.36K 1.98% 14
2017
Q3
$4.05M Buy
47,308
+2,126
+5% +$174K 2.09% 15
2017
Q2
$3.72M Buy
45,182
+1,247
+3% +$102K 2% 15
2017
Q1
$3.69M Buy
43,935
+13
+0% +$1.04K 2.02% 15
2016
Q4
$3.23M Buy
43,922
+1,692
+4% +$126K 1.79% 15
2016
Q3
$3.39M Buy
42,230
+1,500
+4% +$120K 1.9% 14
2016
Q2
$3.21M Sell
40,730
-12,999
-24% -$979K 1.78% 17
2016
Q1
$3.87M Buy
53,729
+630
+1% +$47.7K 1.62% 17
2015
Q4
$4.47M Sell
53,099
-175
-0.3% -$14.5K 1.95% 11
2015
Q3
$4.46M Sell
53,274
-425
-0.8% -$35.9K 2.05% 9
2015
Q2
$4.48M Sell
53,699
-125
-0.2% -$9.53K 1.9% 11
2015
Q1
$3.91M Buy
53,824
+50
+0.1% +$3.56K 1.68% 15
2014
Q4
$3.71M Sell
53,774
-34
-0.1% -$2.29K 1.61% 18
2014
Q3
$3.49M Sell
53,808
-19
-0% -$1.2K 1.54% 19
2014
Q2
$3.35M Buy
53,827
+765
+1% +$45.6K 1.47% 19
2014
Q1
$3.12M Buy
53,062
+225
+0.4% +$12.6K 1.45% 21
2013
Q4
$2.69M Buy
52,837
+3,315
+7% +$166K 1.28% 26
2013
Q3
$2.49M Sell
49,522
-25
-0.1% -$1.31K 1.32% 23
2013
Q2
$2.43M Buy
+49,547
New +$2.7M 1.31% 22

Other funds holding LLY

First Bankers Trust's LLY Position: Q2 2026 in Review

First Bankers Trust increased its Eli Lilly (LLY) stake by 0.73% in Q2 2026, buying an estimated $67.4K and bringing the position to 9,048 shares worth $10.9M. The position accounts for 3.38% of the portfolio, ranked #3.

First Bankers Trust first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. 1,585 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • First Bankers Trust held 9,048 shares of Eli Lilly worth $10.9M as of Q2 2026.
  • First Bankers Trust bought 66 Eli Lilly shares in Q2 2026, an estimated $67.4K.
  • Eli Lilly made up 3.38% of First Bankers Trust's portfolio in Q2 2026, its #3 holding.
  • First Bankers Trust first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
  • 1,585 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on First Bankers Trust's 13F filing for Q2 2026, filed 9 Jul 2026.